Suppr超能文献

染色质修饰机制的组成部分在卵巢透明细胞癌发生中的作用(综述)

The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review).

作者信息

Shigetomi Hiroshi, Oonogi Akira, Tsunemi Taihei, Tanase Yasuhito, Yamada Yoshihiko, Kajihara Hirotaka, Yoshizawa Yoriko, Furukawa Naoto, Haruta Shoji, Yoshida Shozo, Sado Toshiyuki, Oi Hidekazu, Kobayashi Hiroshi

机构信息

Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan.

出版信息

Oncol Lett. 2011 Jul;2(4):591-597. doi: 10.3892/ol.2011.316. Epub 2011 May 16.

Abstract

Recent data have provided information regarding the profiles of clear cell carcinoma of the ovary (CCC) with adenine-thymine rich interactive domain 1A (ARID1A) mutations. The purpose of this review was to summarize current knowledge regarding the molecular mechanisms involved in CCC tumorigenesis and to describe the central role played by the aberrant chromatin remodeling. The present article reviews the English-language literature for biochemical studies on the ARID1A mutation and chromatin remodeling in CCC. ARID1A is responsible for directing the SWI/SNF complex to target promoters and regulates the transcription of certain genes by altering the chromatin structure around those genes. The mutation spectrum of ARID1A was enriched for C to T transitions. CCC and clear cell renal cell carcinoma (ccRCC) resemble each other pathogenetically. Dysfunction of the ARID1A protein, which occurs with VHL mutations in ccRCC, is responsible for loss of the assembly of the ARID1A-mediated histone H2B complex. Therefore, ARID1A acts as a chromatin remodeling modifier, which stimulates cell signaling that can lead to cell cycle arrest and cell death in the event of DNA damage. The dysfunction of ARID1A may result in susceptibility to CCC carcinogenesis through a defect in the repair or replication of damaged DNA.

摘要

近期数据提供了有关伴有腺嘌呤 - 胸腺嘧啶丰富相互作用域1A(ARID1A)突变的卵巢透明细胞癌(CCC)特征的信息。本综述的目的是总结当前关于CCC肿瘤发生所涉及分子机制的知识,并描述异常染色质重塑所起的核心作用。本文综述了关于CCC中ARID1A突变和染色质重塑的生化研究的英文文献。ARID1A负责引导SWI/SNF复合物靶向启动子,并通过改变这些基因周围的染色质结构来调节某些基因的转录。ARID1A的突变谱以C到T的转换为主。CCC与肾透明细胞癌(ccRCC)在发病机制上相似。ccRCC中与VHL突变同时发生的ARID1A蛋白功能障碍,导致ARID1A介导的组蛋白H2B复合物组装缺失。因此,ARID1A作为一种染色质重塑调节剂,在DNA损伤时刺激细胞信号传导,可导致细胞周期停滞和细胞死亡。ARID1A功能障碍可能通过受损DNA修复或复制缺陷导致易患CCC癌变。

相似文献

3
The emerging roles of ARID1A in tumor suppression.ARID1A 在肿瘤抑制中的新兴作用。
Cancer Biol Ther. 2014 Jun 1;15(6):655-64. doi: 10.4161/cbt.28411. Epub 2014 Mar 11.
6
Remodeling of the ARID1A tumor suppressor.ARID1A 肿瘤抑制因子的重塑。
Cancer Lett. 2020 Oct 28;491:1-10. doi: 10.1016/j.canlet.2020.07.026. Epub 2020 Jul 29.
7
The target therapy of ovarian clear cell carcinoma.卵巢透明细胞癌的靶向治疗。
Onco Targets Ther. 2014 Sep 23;7:1647-52. doi: 10.2147/OTT.S49993. eCollection 2014.
8
ARID1A mutations in endometriosis-associated ovarian carcinomas.ARID1A 突变与子宫内膜异位症相关的卵巢癌。
N Engl J Med. 2010 Oct 14;363(16):1532-43. doi: 10.1056/NEJMoa1008433. Epub 2010 Sep 8.
9
Aberrant chromatin remodeling in gynecological cancer.妇科癌症中的异常染色质重塑。
Oncol Lett. 2017 Nov;14(5):5107-5113. doi: 10.3892/ol.2017.6891. Epub 2017 Sep 6.
10

引用本文的文献

6
7
New strategies in ovarian cancer treatment.卵巢癌治疗的新策略。
Cancer. 2019 Dec 15;125 Suppl 24(Suppl 24):4623-4629. doi: 10.1002/cncr.32544.
9
Microduplication of the ARID1A gene causes intellectual disability with recognizable syndromic features.
Genet Med. 2017 Jun;19(6):701-710. doi: 10.1038/gim.2016.180. Epub 2016 Dec 1.

本文引用的文献

1
The role of deubiquitinating enzymes in chromatin regulation.去泛素化酶在染色质调控中的作用。
FEBS Lett. 2011 Jul 7;585(13):2016-23. doi: 10.1016/j.febslet.2010.10.042. Epub 2010 Oct 26.
3
ARID1A mutations in endometriosis-associated ovarian carcinomas.ARID1A 突变与子宫内膜异位症相关的卵巢癌。
N Engl J Med. 2010 Oct 14;363(16):1532-43. doi: 10.1056/NEJMoa1008433. Epub 2010 Sep 8.
4
Epigenetic drivers of genetic alterations.遗传改变的表观遗传驱动因素。
Adv Genet. 2010;70:309-23. doi: 10.1016/B978-0-12-380866-0.60011-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验